Stockscreener 앱 받기
53.92
0.90%
-0.4274
전일 마감가:
$54.35
열려 있는:
$53.92
하루 거래량:
267.92K
Relative Volume:
0.41
시가총액:
$2.49B
수익:
-
순이익/손실:
$-146.66M
주가수익비율:
-19.58
EPS:
-2.7541
순현금흐름:
$-133.21M
1주 성능:
-4.47%
1개월 성능:
+35.06%
6개월 성능:
+34.25%
1년 성능:
-4.33%
1일 변동 폭
$53.01
$54.71
1주일 범위
$53.01
$58.36
52주 변동 폭
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
명칭
Apogee Therapeutics Inc
전화
650-394-5230
주소
221 CRESCENT ST., WALTHAM
APGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
53.91 | 3.68B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.05 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.90 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.71 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.73 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-09-25 | 개시 | RBC Capital Mkts | Outperform |
| 2025-07-07 | 재확인 | BTIG Research | Buy |
| 2025-03-13 | 개시 | Citigroup | Buy |
| 2024-11-25 | 개시 | Canaccord Genuity | Buy |
| 2024-05-10 | 개시 | BofA Securities | Buy |
| 2023-12-20 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | Guggenheim | Buy |
| 2023-08-08 | 개시 | Jefferies | Buy |
| 2023-08-08 | 개시 | Stifel | Buy |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
| 2023-08-08 | 개시 | Wedbush | Outperform |
모두보기
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Apogee Therapeutics (NASDAQ:APGE) Given New $70.00 Price Target at Royal Bank Of Canada - MarketBeat
Is Apogee Therapeutics Inc. stock positioned for digital transformationWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
How to track smart money flows in Apogee Therapeutics Inc.Market Movement Recap & Consistent Profit Trade Alerts - newser.com
Apogee Therapeutics stock price target raised by RBC Capital to $70 - Investing.com South Africa
Craig-Hallum Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq
Craig-Hallum Initiates Coverage on APGE with a 'Buy' Rating and $109 Price Target | APGE Stock News - GuruFocus
Apogee Therapeutics stock initiated with Buy rating at Craig-Hallum By Investing.com - Investing.com Australia
Apogee Therapeutics stock initiated with Buy rating at Craig-Hallum - Investing.com
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis tools2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Apogee Therapeutics to Participate in Upcoming Conferences - The Manila Times
Apogee Therapeutics (NASDAQ: APGE) to join five fireside chats; webcast available - Stock Titan
How to use Fibonacci retracement on Apogee Therapeutics Inc.2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Is Apogee Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Will breakout in Apogee Therapeutics Inc. lead to full recoveryProfit Target & Trade Opportunity Analysis - newser.com
Detecting support and resistance levels for Apogee Therapeutics Inc.Jobs Report & Verified Momentum Stock Ideas - newser.com
Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
How to read the order book for Apogee Therapeutics Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com
Moody Aldrich Partners LLC Takes $939,000 Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Jennison Associates LLC Sells 23,391 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat
Why Apogee Therapeutics (APGE) Is Up 6.1% After $300 Million Raise to Advance APG777 - Yahoo Finance
Using data filters to optimize entry into Apogee Therapeutics Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
Apogee Therapeutics: Plan To Take Standard-Of-Care Status From Dupixent Is Risky (APGE) - Seeking Alpha
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Here's is How to Trade - sharewise.com
Mizuho Securities Keeps Their Buy Rating on Apogee Therapeutics (APGE) - The Globe and Mail
Will Apogee Therapeutics Inc. stock split attract more investorsPortfolio Value Report & Growth Focused Entry Reports - newser.com
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment - TipRanks
Apogee Therapeutics’ New Study on Atopic Dermatitis: What Investors Need to Know - TipRanks
Apogee Therapeutics Inc (APGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):